关注
Kylee Kus
Kylee Kus
在 ccf.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Basal cell carcinoma review
DP Kim, KJB Kus, E Ruiz
Hematology/Oncology Clinics 33 (1), 13-24, 2019
2912019
Wound dressings–a practical review
KJB Kus, ES Ruiz
Current Dermatology Reports 9, 298-308, 2020
902020
Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: a dual-center …
ES Ruiz, KJB Kus, TD Smile, F Murad, G Zhou, EO Ilori, JD Schoenfeld, ...
Journal of the American Academy of Dermatology 87 (1), 87-94, 2022
262022
Implications of satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: a prognostic omission in cancer staging systems
TD Smile, ES Ruiz, KJB Kus, F Murad, W Wei, DD Xiong, AT Vidimos, ...
JAMA dermatology 158 (4), 390-394, 2022
162022
Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion
KJB Kus, F Murad, TD Smile, M Chang, S Ashrafzadeh, G Zhou, EO Ilori, ...
Journal of the American Academy of Dermatology 86 (4), 766-773, 2022
132022
Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study
MS Min, K Kus, N Wei, B Kassamali, A Faletsky, A Mostaghimi, ...
British Journal of Dermatology 186 (6), 1035-1037, 2022
122022
Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sarcoidosis
B Kassamali, C Villa-Ruiz, KJB Kus, DR Mazori, AA Kassamali, O Gizelis, ...
Journal of the American Academy of Dermatology 86 (5), 1178-1180, 2022
102022
Non-surgical treatments for keratinocyte carcinomas
KJB Kus, ES Ruiz
Advances in Therapy, 1-14, 2021
82021
Evaluating patient experience and satisfaction with teledermatology for isotretinoin management: a structured qualitative interview study
N Shah, B Kassamali, MS Lee, K Kus, AH LaChance, RA Vleugels, ...
Journal of Dermatological Treatment 33 (5), 2698-2701, 2022
62022
Importance of nose wires in face masks: A reply to “Diagnostic and management considerations for “maskne” in the era of COVID-19”
B Kassamali, KJB Kus, MS Min, GA Cobos, AH LaChance, DR Mazori
Journal of the American Academy of Dermatology 85 (3), e151-e152, 2021
52021
OnabotulinumtoxinA for Systemic Sclerosis-associated Raynaud’s Phenomenon: A Multi-Institutional Study on Accessibility and Effectiveness
B Kassamali, S Desai, MS Min, DR Mazori, C Villa-Ruiz, KJB Kus, ...
Journal of Drugs in Dermatology 20 (11), 1257-1258, 2021
42021
Recognition and management of cutaneous connective tissue diseases
KJB Kus, AH LaChance, RA Vleugels
Medical Clinics 105 (4), 757-782, 2021
42021
Characteristics and treatment of silicone granulomas: a retrospective multicenter cohort of 21 patients
B Kassamali, KJB Kus, MS Min, C Villa-Ruiz, GA Cobos, JF Merola, ...
JAAD international 3, 111-114, 2021
42021
Identification of skin cancer screening visits using claims data
KJB Kus, PS Karia, CD Schmults, ES Ruiz
Journal of the American Academy of Dermatology 82 (2), 504, 2019
42019
Cost of skin cancer-related dermatological care is higher in transplant recipients compared with nonimmunosuppressed patients
KA O’Connell, MK Groover, S Lim, KJB Kus, N Gupta, F Murad, ES Ruiz
Journal of the American Academy of Dermatology 90 (1), 150-152, 2024
12024
Race and gender differences in systemic sclerosis: a retrospective multicenter cohort
B Kassamali, KJB Kus, DR Mazori, J Maher, CG Lopez, AA Kassamali, ...
International journal of dermatology 61 (11), e437-e438, 2022
12022
Streamlining Care for Skin Cancers in the COVID-19 pandemic
KJB Kus, A Waldman, ES Ruiz
Dermatologic Surgery 47 (7), 1011-1012, 2021
12021
52344 Clinical Manifestations of Cutaneous Polyarteritis Nodosa: A Multicenter Cohort of 30 Patients
N Zangenah, B Kassamali, K Kus, J Maher, AA Kassamali, D Mazori, ...
Journal of the American Academy of Dermatology 91 (3), AB160, 2024
2024
Physician values in alopecia areata treatment decision-making: A qualitative assessment
JJ Han, P Manjaly, KJ Lee, B Kassamali, KJB Kus, LM Pérez-Chada, ...
JAAD international 11, 14-23, 2023
2023
OnabotulinumtoxinA for Systemic Sclerosis-associated Raynaud’s Phenomenon: A Multi-Institutional Study on Accessibility and Effectiveness
BA Bina Kassamali, BS Sheena Desai, S Michelle, R Daniel, C Villa-Ruiz, ...
LETTERS TO THE EDITOR, 1257, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20